 |
Monovalent replication-incompetent adenovirus serotype 26 (Ad26) vaccine, AD26.ZEBOV in combination with multivalent replication-defective Modified Vaccinia Ankara (MVA)-Bavarian Nordic (BN) vaccine, MVA-mBN226B |
|---|---|
| Trade Name | |
| Orphan Indication | Ebola |
| USA Market Approval | USA |
| USA Designation Date | 2017-01-11 00:00:00 |
| Sponsor | Crucell Holland B.V.;Archimedesweg 4-6;Leiden |
